NIVOSET Trademark

Trademark Overview


On Friday, August 11, 2023, a trademark application was filed for NIVOSET with the United States Patent and Trademark Office. The USPTO has given the NIVOSET trademark a serial number of 98128462. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, October 31, 2024. This trademark is owned by Medytox Inc.. The NIVOSET trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; muscle relaxants; anaesthetics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical preparations acting on the central nervous system; biological preparations for medical purposes being bacterial and bacteriological preparations; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain
nivoset

General Information


Serial Number98128462
Word MarkNIVOSET
Filing DateFriday, August 11, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; muscle relaxants; anaesthetics; pharmaceutical agents affecting peripheral nervous system; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical preparations acting on the central nervous system; biological preparations for medical purposes being bacterial and bacteriological preparations; implantable medicines being medicinal infusions, injectable gels, injectable pharmaceuticals for use in the treatment of neurological disorders and muscle dystonia; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedytox Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do 28126
KR

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2023NEW APPLICATION ENTERED
Monday, September 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 18, 2023SUSPENSION LETTER WRITTEN
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Monday, September 18, 2023LETTER OF SUSPENSION E-MAILED
Monday, September 18, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 3, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, April 3, 2024INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 3, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, October 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 10, 2024ASSIGNED TO LIE
Thursday, October 31, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 31, 2024LETTER OF SUSPENSION E-MAILED
Thursday, October 31, 2024SUSPENSION LETTER WRITTEN
Monday, March 18, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, June 25, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED